Table 1.
Characteristics of the individual participants.
| Patient ID | S1 | S2 | S3 | S4 | |
| Age | 49 | 49 | 78 | 80 | |
| Date of Stroke* | 25/04/04 | 15/07/04 | 31/01/05 | 03/01/05 | |
| Date of Testing* | 28/06/04 | 23/08/04 | 23/02/05 | 15/02/05 | |
| Time from stroke to testing (months) | ~2 | ~1 | ~1 | ~1.5 | |
| Location of stroke | Left interior capsule | Right pontine lacunar | Left cerebellar | Left lacunar | |
| Medication(s) | Atorvastatin Perindopril | Losartan HCTZ Plavix Nifedipine | Diazepam Glycerin Atorvastatin Heparin Sodium ASA | Plavix Rampril HCTZ Cardizem | |
| NIHSS** (adm/disch**) | 3/3 | 5/3 | 1/1 | 5/2 | |
| CMSA leg score (adm/disch) | 6/6 | 4/5 | 6/6 | 3/4 | |
| FIM** (adm/disch) | 100/115 | 61/106 | 74/103 | 88/107 | |
| FIM (locomotion; adm/disch) | 6/7 | 5/5 | 4/6 | 2/6 | |
| FIM (upper body; adm/disch) | 6/7 | 3/6 | 5/6 | 4/6 | |
| Resting HR** (day of testing; bpm) | 79 | 71 | 53 | 62 | |
| Lower limit target HR training zone (bpm) | 105 | 101 | 77 | 88 | |
| Peak demonstrated HR | 113 | 107 | 97 | 110 | |
| Peak demonstrated VO2 (ml/kg/min) | 12.8 | 10.4 | 15.2 | 8.9 | |
| Amount of time in each activity category (AC) [10] | |||||
| Activity Categories | 0 | 8% | 2% | 26% | 52% |
| 1 | 51% | 21% | 28% | 13% | |
| 2 | No samples; see text for explanation | ||||
| 3 | 21% | 20% | 24% | 20% | |
| 4 | 20% | 57% | 22% | 15% | |
* dates are formatted as dd/mm/yyyy
**NIHSS-National Institutes of Health Stroke Score, FIM-Functional Independence Measure, adm/disch-score at admission/score at discharge, HR-heart rate